<ul data-eligibleForWebStory="true"><li>Nabla, a widely adopted AI assistant in clinical care, raises $70M in Series C funding led by HV Capital.</li><li>Highland Europe and DST Global join as key investors, bringing Nabla's total capital raised to $120M.</li><li>The funding will accelerate product development, fuel team growth, and support strategic partnerships for expansion.</li><li>Nabla is transitioning from ambient documentation to a more agentic AI model for clinical use.</li><li>The next phase aims to improve clinical documentation integrity, initiate EHR actions, and support diverse clinical roles.</li><li>Nabla plans to build an Adaptive Agentic Platform with features like Proactive Coding Agent and Context-Aware Agent.</li><li>The platform is expanding into various care settings to streamline clinical workflows.</li><li>Nabla's assistant is used by major health systems like CVS Health and has seen revenue multiply by five in the past six months.</li><li>The platform supports over 85,000 clinicians, with measurable results in reducing documentation time and improving patient satisfaction.</li></ul>

Nabla Raises $70M to Build an “Agentic” AI Assistant for Clinicians

Discover more